Hair Loss: Causes, Assessment & Nursing Guide
⚡ At-a-Glance Nursing Summary
- Pattern: diffuse shedding on the pillow versus discrete patches; tempo (weeks versus months) and prior baseline
- Scalp and hair-bearing skin: scale, erythema, tenderness, pustules, or scarring clues—compare with photos if available
- Medications and treatments: chemotherapy, anticoagulants, retinoids, hormonal agents; note start dates relative to shedding
- Systemic review: weight change, fatigue, menstrual changes, arthralgia, or fever when endocrine or autoimmune disease is possible
- Hair practices: tight braids, chemical relaxers, heat, traction—document without judgment
- Painful, boggy, or purulent scalp with fever—possible infection; urgent assessment
- Rapidly expanding patchy loss with inflammatory scalp or systemic symptoms
- Scarring clues: smooth shiny skin, loss of follicles, or permanent margins—early dermatology review
- Non-scalp findings with acute illness: petechiae, mucosal bleeding, or pancytopenia concern—do not attribute to “stress alone”
- Widespread loss with signs of severe psychiatric or self-harm concern—safety pathways when indicated
- New inflammatory scalp or children with patchy loss plus lymphadenopathy—provider review per protocol
- Oncology patient with scalp symptoms during neutropenia—lower threshold for infection pathways
- Suspected traction or chemical injury with open areas—wound and dermatology coordination
- Psychosocial crisis from visible hair loss—behavioral health or social work referral when available
- Any documentation of rapid progression or unclear diagnosis despite stable vitals—avoid “watchful waiting” without a plan
When hair Loss is the chief concern, triage hinges on clustering features rather than any single finding. Pair the symptom with vitals, risk factors, and associated signs you can observe and record.
Below is a structured path from first report to clear escalation triggers.
Definition
Hair loss (often termed alopecia) describes increased shedding, visible thinning, or bald patches when hair production slows or follicles are damaged. Patients may say their hair is “falling out in clumps,” “seeing more on the brush,” or “noticing a receding line.” The complaint is common in primary care, dermatology, oncology units, postpartum, and mental health—yet it is not one disease at the bedside.
Increased hair loss may be associated with telogen effluvium after stress or illness, androgenetic pattern, inflammatory scalp disorders, traction or chemical injury, medication effects, nutritional deficiency, or endocrine and autoimmune conditions—among other contributors. Nurses document onset, pattern, associated symptoms, and objective scalp findings; clinicians determine diagnosis and management. For a broader overview of the condition label, see how alopecia may be framed in specialist resources—without replacing individualized assessment.
Hair loss often overlaps with distress, body-image concerns, and—when inflammatory—scalp symptoms. Pair the complaint with tempo, distribution, and systemic features rather than charting “hair loss” alone.
Alopecia is an umbrella term for hair loss from any cause; telogen effluvium describes increased shedding of telogen hairs after a trigger, while androgenetic alopecia follows a patterned thinning. Bedside nursing focuses on pattern, red flags, and escalation—not on naming a subtype without training.
Common Causes of Hair Loss
Frameworks below support pattern recognition. Each item may be associated with shedding or thinning; confirmation requires evaluation.
- Telogen effluvium: diffuse shedding months after fever, surgery, psychological stress, or postpartum—often self-limited when the trigger resolves.
- Androgenetic pattern: gradual thinning in a characteristic distribution; family history may be relevant.
- Alopecia areata: autoimmune inflammatory patches; may be associated with nail pitting—dermatology-directed diagnosis.
- Endocrine disease: hypothyroidism and other disorders may be associated with diffuse thinning—labs and exam guide clinicians.
- Nutritional deficiency: iron deficiency and other deficiencies may be associated with shedding—clinicians interpret results; iron deficiency anemia is one context-dependent example.
- Autoimmune and inflammatory: lupus and psoriasis may be associated with hair symptoms—patterns differ.
- Medications and treatments: chemotherapy, anticoagulants, retinoids, and other agents may be associated with shedding—clinicians review causality.
- Traction and mechanical: tight hairstyles, extensions, or chemical damage may injure follicles over time.
- Hormonal (example): polycystic ovary syndrome may be associated with androgen-related scalp changes in some patients—evaluation is clinician-led (see PCOS for condition context).
How This Typically Presents in Clinical Settings
ED / Urgent care
- Scalp infection, abscess, or necrotizing soft-tissue concerns with fever, purulent drainage, or severe pain—triage before attributing to routine shedding
- Acute widespread hair loss with mucosal bleeding, petechiae, or systemic toxicity—broader hematology or emergency pathways when indicated
- Chemical scalp burn or trauma—irrigate and follow trauma protocols; cosmesis follow-up is secondary to stabilization
General ward / Medical–surgical
- Diffuse shedding after critical illness, surgery, or sepsis—may be associated with telogen effluvium months later; document timeline
- Oncology patients receiving chemotherapy or targeted therapy—anticipatory education and scalp cooling per protocol when ordered
- Postpartum patients reporting increased shedding—often benign; still screen for anemia, thyroid symptoms, or mood concerns per scope
ICU
- Prolonged illness, drugs, and nutritional stress may cluster with hair shedding in recovery—pair with rehabilitation and follow-up planning
- Immunosuppression and lines lower the threshold for scalp infection review when localized pain or fever appears
Outpatient / Primary care / Community
- Gradual thinning in a characteristic pattern—often chronic; education and follow-up when red flags are absent
- Patchy loss with nail pitting or personal/family history of autoimmune disease—may prompt referral communication
Common Signs and Symptoms Nurses Observe
- Increased hair on the pillow, shower drain, or brush; patient may bring a bag of shed hair
- Widening part line, receding hairline, or vertex thinning in androgenetic patterns when described
- Round or oval patches of complete loss on scalp, beard, or eyebrows
- Scalp erythema, scale, pustules, tenderness, or malodor—raises concern beyond simple shedding
- Broken hairs or fringe pattern at margins when traction is suspected
- Nail pitting, trachyonychia, or other nail changes when inflammatory alopecia is possible
- Associated fatigue, weight change, menstrual irregularity, or arthralgia—systemic context for clinician evaluation
Nursing Interpretation
Connect reported pattern to mechanisms without assigning a definitive diagnosis.
| Finding | Clinical interpretation |
|---|---|
| Diffuse shedding 2–3 months after fever, surgery, or major stress | May be associated with telogen effluvium—temporal relationship matters; clinicians confirm pattern |
| Patchy smooth bald spots with “exclamation-point” hairs | May be associated with alopecia areata—dermatology-directed evaluation |
| Gradual frontal/top thinning with preserved posterior hair in women | May be associated with androgenetic pattern—differentiate from other causes by exam |
| Scalp redness, scale, pustules, tenderness, or malodor | May be associated with inflammatory scalp disorders or infection—urgent escalation when systemic signs appear |
| Hair loss along margins of tight braids or extensions | May be associated with traction injury—behavior change and dermatology input may be needed |
Early or Subtle Signs Nurses Should Not Miss
- “More hair than usual” after pregnancy, illness, or weight loss—patients may minimize until shedding is obvious
- Mild scalp tenderness before visible loss—pair with medication review when new drugs are involved
- Children with patchy loss and cervical lymphadenopathy—lower threshold for physician exam
- Oncology patient with new scalp discomfort during neutropenia—document and escalate per protocol
Triage patterns across common presentations
| Presentation pattern | Likely associations (examples) | Priority |
|---|---|---|
| Fever, purulent scalp, severe pain, systemic toxicity | Cellulitis, abscess, necrotizing infection | Emergency — urgent medical and surgical review |
| Rapid patchy loss with nail pitting or autoimmune history | Alopecia areata, inflammatory disease | Urgent — dermatology / rheumatology pathways |
| Diffuse shedding months after trigger, stable vitals | Telogen effluvium | Routine–urgent — outpatient follow-up when stable |
| Gradual patterned thinning without inflammation | Androgenetic alopecia | Routine — longitudinal care when cosmesis or distress is the primary concern |
How This Differs by Patient Population
Older adults
- Gradual thinning may be common with age, but new rapid loss or inflammatory scalp still warrants evaluation
- Polypharmacy increases medication-related shedding risk; reconciliation matters
Pediatric patients
- Tinea capitis may present with scaling, broken hairs, or lymphadenopathy—school-age exposure history
- Trichotillomania may mimic patchy loss; sensitive psychosocial assessment
Pregnant and postpartum patients
- Telogen effluvium may be associated with postpartum timing—still screen for thyroid symptoms or anemia when indicated
Oncology and immunosuppression
- Chemotherapy-induced hair loss is often expected; scalp infection is not—neutropenic fever pathways apply
Red-Flag Symptoms Requiring Urgent Action or Escalation
- Painful, boggy, or purulent scalp with fever—possible infection; urgent assessment
- Rapidly expanding patchy loss with inflammatory scalp or systemic symptoms
- Scarring clues: smooth shiny skin, loss of follicles, or permanent margins—early dermatology review
- Non-scalp findings with acute illness: widespread petechiae, mucosal bleeding, or severe pallor—do not attribute to stress alone
- Hair loss with suicidal ideation or severe functional impairment—behavioral health and safety pathways when indicated
Do not dismiss focal scalp tenderness, fever, or purulent drainage as “just stress shedding” without clinician assessment—scalp infections and systemic illness can evolve quickly.
Focused nursing assessment
ABCs and context
- When fever, hypotension, or rapid systemic illness occurs, prioritize escalation over detailed history minutiae
- Otherwise gather onset, tempo, pattern, hair practices, recent illness, pregnancy status, and medication changes
Focused scalp and hair review (within scope)
- Inspect pattern and distribution; note patchy versus diffuse; compare with prior photos if available
- Observe scale, erythema, pustules, crusting, tenderness, or scarring—avoid forceful pulling
- Check eyebrows, lashes, and body hair when relevant; note nail changes
Medication and treatment context
- Reconcile chemotherapy, anticoagulants, retinoids, hormonal agents, and new prescriptions; note start dates
- Ask about salon chemicals, home dyes, relaxers, and traction styles
Immediate Non-Pharmacological Nursing Interventions
Psychosocial support
- Validate distress about visible hair loss; offer privacy for head covering or wig adjustment
- Facilitate interpreter or culturally sensitive discussion when hair carries religious or identity weight
Scalp comfort and safety (within scope)
- Follow prescribed topical therapy; do not substitute shampoos or steroids
- Avoid harsh brushing on inflamed areas; use gentle handling per plan
Education and coordination
- Reinforce return precautions for fever, purulent drainage, or rapid spread—without naming a diagnosis
- Coordinate oncology or dermatology appointments when ordered; document teaching
Infection prevention
- Standard precautions for scalp assessment; follow isolation policy if open infection is suspected
Nursing Documentation Focus
- Onset, pattern (diffuse versus patchy), tempo, and prior baseline when known
- Scalp and hair-bearing skin findings visible within scope; nail changes if observed
- Medications, chemotherapy cycle, hair practices, and recent stressors or illness
- Psychosocial impact, education provided, escalations with times
“1045: Pt reports increased hair shedding x6 weeks after hospitalization for pneumonia. Diffuse thinning on crown without focal scalp pain. No fever. Notes fatigue; endocrine follow-up scheduled. HR 78, BP 118/76, T 36.9°C. Scalp without erythema or pustules on brief inspection per protocol. Medication list reviewed; no new agents. PCP aware; return precautions for scalp pain, fever, or rapid patchy loss reviewed.”
How This Sign/Symptom Progresses if Untreated
- Telogen effluvium may improve over months when the trigger resolves—trend documentation matters
- Inflammatory or scarring alopecia may be associated with permanent loss without treatment—early dermatology input protects follicles
- Untreated scalp infection may progress to deeper soft-tissue involvement—timely escalation matters
Tempo separates many benign patterns from emergencies: gradual thinning over years differs from painful patchy loss over days—document both in the patient’s words and your objective findings.
Clinical Signs of Deterioration and When to Escalate
Pair with facility early warning systems and dermatology, infectious disease, or emergency access pathways.
- Hemodynamic instability, confusion, or sepsis concern with scalp or systemic findings
- Suspected necrotizing soft-tissue infection or rapidly spreading craniofacial erythema
- Fever with purulent scalp, severe tenderness, or immunocompromise
- Rapid patchy loss with inflammatory scalp or lymphadenopathy in a child
- Stable chronic patterned thinning: document explicit return precautions for pain, fever, or new inflammatory scalp signs
Clinical Pearls
- The “hair pull” test may be used in some settings by trained clinicians—do not perform unsanctioned tests; document what you observe within scope
- Chemotherapy hair loss is often anticipated; infection is not—keep thresholds low when neutropenic
- Body-image distress is common; a few minutes of non-judgmental listening can clarify referral needs
Chronic illness questions patients search (life impact & coping)
These phrases reflect common patient search language (plain-language intent), including seriousness, urgency, and when-to-seek-care queries that often accompany symptom searches. This block is written for clinicians and nurses: use it to guide history-taking, anticipate concerns, and align education—not as direct answers to give patients verbatim.
| Patient question (search language) | How to use this in practice (staff) |
|---|---|
| Will this affect my daily life long-term? | Opens goals, occupational impact, and follow-up planning. |
| What lifestyle changes actually help? | Maps to evidence-based self-management without diagnosing. |
| How do I explain this to family or work? | Stigma and disclosure; coordinate education and reasonable adjustments messaging. |
| Is it normal to feel anxious or low with this? | Psychosocial screening language; escalate per mental-health pathways when appropriate. |
| Why do symptoms come and go? | Expect variability; document pattern, triggers, and remission periods. |
| What should I track between visits? | Symptom diaries and trends—supports shared decision-making. |
Frequently Asked Questions (FAQ)
1. Is hair loss always permanent?
No. Telogen effluvium and some medication-related shedding may improve when the trigger resolves or therapy is adjusted; scarring alopecia can be irreversible without early treatment. Nurses document tempo, pattern, and scalp findings; permanence is a medical determination.
2. When should hair loss prompt urgent medical review?
Seek urgent pathways for painful inflamed scalp, rapid progression, fever with scalp infection concern, widespread hair loss with systemic symptoms, or signs suggesting scarring—per local emergency and dermatology criteria.
3. Can thyroid problems cause hair loss?
Thyroid dysfunction may be associated with diffuse shedding or thinning in some patients; clinicians correlate labs and exam. Nurses note associated symptoms such as cold intolerance, palpitations, or weight change and support ordered follow-up without interpreting results.
4. How should nurses document hair loss at the bedside?
Record onset, pattern (diffuse versus patchy), tempo, scalp symptoms, recent illness or stress, medications, hair practices, and psychosocial impact. Note objective findings visible within scope and escalation steps with times.
5. Is chemotherapy-related hair loss preventable?
Scalp cooling may reduce chemotherapy-induced hair loss in some protocols when available and ordered; eligibility and logistics vary by regimen and center. Nurses follow oncology unit protocols and document teaching and tolerance.
6. Should nurses recommend over-the-counter hair growth products?
Reinforce clinician-directed plans only. OTC topicals may be appropriate for some patients when prescribed or explicitly approved by the treating team; avoid product-specific advice beyond scope and institutional policy.
7. When is dermatology referral appropriate?
Referral thresholds depend on presentation: patchy loss, inflammatory scalp, uncertain diagnosis, failed first-line therapy, or cosmetic distress warrant coordinated specialty access per local pathways—not routine reassurance alone.
References
[1] National Institute for Health and Care Excellence. Thyroid disease: assessment and management. NG145 — use current update for primary care and referral principles. https://www.nice.org.uk/guidance/ng145
[2] American Academy of Dermatology. Hair loss: diagnosis and treatment (public education context for lay language). https://www.aad.org/public/diseases/hair-loss
[3] National Institute for Health and Care Excellence. Anaemia — iron deficiency: management. NG23 — use current update for investigation and treatment principles. https://www.nice.org.uk/guidance/ng23
[4] Al Aboud AM, Zito PM. Alopecia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2026. https://www.ncbi.nlm.nih.gov/books/NBK538178/
[5] World Health Organization. Skin diseases — fact sheet. https://www.who.int/news-room/fact-sheets/detail/skin-diseases
[6] Sinclair R, Patel M, Dawson TL Jr, et al. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness. Br J Dermatol. 2011;165(1):12-18. doi:10.1111/j.1365-2133.2011.10630.x
Disclaimer: This content is for informational and educational purposes only and is intended for nursing professionals and students. It supports assessment and communication; it does not replace medical diagnosis, prescribing decisions, or licensed clinician judgment. Nursing practice focuses on objective observation, trending, and escalation per protocol—not labeling a condition at the bedside. Clinical assessment requires correlation with history, examination, and diagnostic testing. This information does not replace clinical judgment, institutional protocols, or current evidence-based practice guidelines. Not medical advice. Always follow your facility’s specific policies and escalation procedures. No conflicts of interest to disclose.